Romosozumab May Be the Next Big Treatment for Osteoporosis
This monoclonal antibody binds to sclerostin, thus stimulating bone formation. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - February 11, 2014 Category: OBGYN Authors: Medscape Source Type: podcasts
Osteoporosis – prevention and detection in general practice
Dr Dan Ewald is a GP and public health physician from the NSW who discusses osteoporosis prevention and detection in general practice, telling us what the evidence shows and reminding us of the importance of sorting the evidence from the hype. (Source: Australian Family Physician audio)
Source: Australian Family Physician audio - February 29, 2012 Category: Primary Care Authors: The Royal Australian College Of General Practitioners Tags: Podcasts Source Type: podcasts
Bones beyond 70 – insights into osteoporosis management in the elderly
Osteoporosis is a major health concern with an aging population. Professor Charles Inderjeeth discusses his research based on a clinical audit about the current assessment and management of osteoporosis in those aged 70 years or more which found areas that can be improved (Source: Australian Family Physician audio)
Source: Australian Family Physician audio - September 30, 2010 Category: Primary Care Authors: The Royal Australian College Of General Practitioners Tags: Podcasts Source Type: podcasts
The Lancet: May 02, 2008
Authors of a research Article discuss in this week's podcast how two genetic variants of key biological proteins increase both the risk of osteoporosis and osteoporotic bone fractures. As these variants are present in more than one in five people, the investigators conclude that there is a potential role for screening. An accompanying Comment describes the report as an important step towards understanding the genetic basis of osteoporosis. (Source: Listen to The Lancet)
Source: Listen to The Lancet - May 2, 2008 Category: General Medicine Authors: The Lancet Source Type: podcasts
Bone Health and Osteoporosis (October, 2007)
Enhanced Audio PodcastPresented by: Vivian W. Pinn, M.D., Director, The Office of Research on Women's HealthAired date: 10/24/2007 11:18:00 AM Eastern Time (Source: ORWH Podcasts)
Source: ORWH Podcasts - December 19, 2007 Category: Consumer Health News Authors: Office of Research on Women's Health Tags: Health Source Type: podcasts
JAMA: 2006-06-21, Vol. 295, No. 23, Author in the Room Audio Interview
Interview with Victor G. Vogel, MD, MHS, author of Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes , published in the June 21 issue of JAMA, the Journal of the American Medical Association. Summary Points: 1. Raloxifene is as effective in reducing the risk of invasive breast cancer in postmenopausal women who are at increased risk of the disease. 2. The safety profile of raloxifene is more favorable than tamoxifen with fewer hysterectomies, uterine malignancies, serious thrombotic events, and cataracts. 3. Both physicians and patients are familiar with raloxife...
Source: JAMA Author in the Room - July 19, 2006 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Osteoporosis guidelines updated
(Source: MedlinePlus: NLM Director's Comments)
Source: MedlinePlus: NLM Director's Comments - May 15, 2006 Category: Databases & Libraries Authors: National Library of Medicine Source Type: podcasts
Vitamin D Supplements may not Prevent Osteoporosis
(Source: MedlinePlus: NLM Director's Comments)
Source: MedlinePlus: NLM Director's Comments - May 15, 2006 Category: Databases & Libraries Authors: National Library of Medicine Source Type: podcasts
